CClinicalTrials.gg
CompletedNCT02717429CERT-MSUpdated Apr 17, 2018

Cognitive and Emotion Regulation Training in MS

An interventional study of Mindfulness Meditation and Computerized Cognitive Training in Multiple Sclerosis, sponsored by Ohio State University. Completed at 1 site in United States. Open to participants aged 30 Years to 59 Years. Per ClinicalTrials.gov, last updated 2018-04-17.

Sponsored by Ohio State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
30 Years to 59 Years
Sex
All
01

Study summary

The investigators propose to conduct a randomized feasibility study of mindfulness meditation training (MMT) relative to an active cognitive training control group and waitlist control group in improving emotional regulation in individuals with MS. Individuals will complete pre- and post-assessments of emotional functioning through a week of daily diary entries, as well as self-report measures and a behavioral paradigm. Additionally, all participants will complete an evaluation of neuropsychological functioning, before and after intervention.

Read the detailed description

Epidemiological data provides evidence for the manifold increase in rates of depression and anxiety in individuals diagnosed with multiple sclerosis, relative to the general population. Such impaired affective processes, including deficits in emotion regulation have been linked to greater cognitive deficits, a lower quality of life, and greater disease progression in this population. Despite evidence of the deleterious impact of affective functioning on prevalence rates of mood and anxiety disorders; on poor cognitive functioning; and reduced quality of life, much of the targeted intervention research in MS has not directly tested the feasibility, and subsequent efficacy of a psychosocial intervention in improving affective regulation in this population. Thus, the investigators propose to conduct a randomized feasibility study of mindfulness training relative to an active cognitive training control group and waitlist control group in improving emotional regulation in individuals with MS. All individuals that contact the Clinical Neuroscience Laboratory (CNLab) with interest in this study will undergo a phone screening assessing inclusion/exclusion criteria. Those participants meeting I/E criteria will be invited for an online daily diaries portion of the study examining daily engagement in worry and rumination. After completing the week-long daily diary portion of the study, the participant will attend 1-2 in-person pre-assessment sessions, which will also be completed at the completion of the four week intervention. The pre-assessment will involve a thorough assessment of emotion regulation skills, both through self-report questionnaires and behavioral paradigms, and cognitive functioning. Following the assessment sessions, which will be conducted by blind assessors, participants will be randomized to the three groups. The 4-week mindfulness program will be closely modeled after the protocol developed by Dr. Jon Kabat-Zinn, where investigators will have the participants attend once-per-week sessions for 2 hours and complete around 40 minutes a day of homework assignments. The four weeks of mindfulness involve the practice of concentrative attention, where different objects are used as the focus of practices. For example, for the first two weeks, the investigators use breath as an anchor for the mind. With repeated practices, the objects of sensations, emotions, and thought processes are introduced. The classes are a mixture of experiential practices, discussions surrounding the experiences, and didactics on mindfulness. The control group, which will be used to compare the effects of mindfulness training on emotional and cognitive functioning of MS patients, will comprise of a cognitive training group, which will provide an attentional-training based approach. In this group, our focus will be to provide the individuals with cognitive training tasks to complete that have been shown to improve attentional ability. Homework will be reading and practicing using the cognitive video game exercises for the same duration, around 40 minutes daily, as the mindfulness group. Following the four weeks of the intervention, the questionnaires, week-long daily diaries, and behavioral tests from the pretest will be repeated a second time to obtain post-test data for comparison.

02

Conditions studied

  • Multiple Sclerosis
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's enrollment of 62 is above the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Ohio State University is the lead sponsor of 640 studies on the registry; 144 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 45 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. 30-59 years of age
  2. Score higher than or equal to 23 on the Mini Mental Status Examination (MMSE)
  3. Corrected (near and far) visual acuity of 20/40 or better
  4. No previous experience with mindfulness or continuous meditation practice
  5. Absence of other co-morbid neurological disorders
  6. Relapse free for the last 30 days
  7. No use of corticosteroids for the last 30 days
  8. Clinically definite diagnosis of MS
  9. Ability to use a computer and connect the internet from their home
  10. Generation of at least two worries and two ruminations during the daily diary portion of the study for the pre-assessment session

Exclusion criteria

Exclusion Criteria:

  1. Below 30 years of age or above 59 years of age
  2. Score lower than 23 on the MMSE
  3. Corrected (near or far) visual acuity of 20/40 or greater
  4. Previous experience or participation in a mindfulness program
  5. Presence of co-morbid neurological disorders such as:

    • Alzheimers
    • Parkinson's disease
    • Dementia
  6. Presence of a relapse within the last 30 days
  7. Use of corticosteroids within the last 30 days
  8. Clinically isolated syndrome suggestive of MS
  9. No ability to use a computer and/or a lack of internet connection from their home
  10. No self-generated worries and ruminations in the week-long daily diary portion of the study at pre-assessment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Mindfulness Meditation Training (MMT)

    Participants will attend four weekly group mindfulness meditation sessions of a 2-hour duration. The classes are a mixture of experiential practices, discussions surrounding the experiences, and didactics on mindfulness. In addition to the time spent in session, participants will be asked to complete 40 minutes of daily homework, which includes further practice of in-session meditative exercises and brief readings.

    Behavioral: Mindfulness Meditation

  • Active comparator
    Computerized Cognitive Training

    The active control group will be in the form of a cognitive training course where the participants will meet for the same amount of time as the MMT group. Homework will be reading and engaging in cognitive video game exercises for the same duration, around 40 minutes daily, as the MMT group.

    Behavioral: Computerized Cognitive Training

  • No intervention
    Wait-List Control Group

    This group will be used to compare the effects of the two active comparison groups and will not receive any intervention for the four week period.

Interventions

  • BehavioralMindfulness Meditation

    The mindfulness meditation-training program is closely modeled after the 8-week mindfulness based stress reduction protocol developed by Dr. Jon Kabat-Zinn. The briefer four weeks of MMT involve the practice of concentrative attention, where different objects are used as the focus of meditative practices. For example, for the first two weeks, the investigators use breath as an anchor for attention. With repeated practices, the objects of sensations, emotions, and thought processes are introduced.

  • BehavioralComputerized Cognitive Training

    The control group, which will be used to compare the effects of mindfulness training on emotional and cognitive functioning of MS patients, will comprise of a cognitive training group, which will provide an attentional-training based approach. In this group, the focus will be to provide the individuals with cognitive training tasks to complete that have been shown to improve attentional ability. The investigators will also discuss relevant MS-related material on cognitive deficits during these courses.

06

What researchers measure

Primary outcomes

  1. Change in Reported Engagement After Worry and Rumination Inductions

    Participants will engage in worry and rumination inductions during both the pre- and post-intervention sessions. These worries and ruminations will be sampled from the daily diaries participants will fill out 7-days before the pre- and post-intervention sessions. Investigators will be examining the change in emotion and strategy implementation over the course of the worry and rumination inductions. Specifically, investigators will examine the change in reported negative and positive emotion related to the worry and rumination inductions from pre- to post-intervention. Further, investigators will examine the induction-related change in strategy implementation, specifically worry and rumination, over the 4-weeks of intervention.

    Time frame: Baseline and 4 weeks

Secondary outcomes

  1. Cognitive Performance on Brief Repeatable Battery (BRB)

    Participants will perform the entire Brief Repeatable Battery before and after the intervention. Using the categorization developed by Sepulcher (2013), the 5 tests of the BRB will be analyzed using four cognitive domains: attention and executive functioning, verbal memory, visual memory, and word fluency. Based on the computerized cognitive training protocol employed in the current study, investigators hypothesize changes in attention and executive functioning along with visual memory in participants in the cognitive training group, followed by participants in the MMT group compared with the wait-list control participants.

    Time frame: Baseline and 4 weeks

  2. Heart Rate Variability (HRV)

    HRV data will be collected during worry and rumination inductions, as participants regulate their emotions, and at rest.

    Time frame: Baseline and 4 weeks

  3. Daily Emotion Regulation Diary

    Participants will be asked to fill out worry and ruminations using a diary-based methodology a week before the pre-intervention behavioral session and one week after the post-intervention sessions. Changes in average self-reported worry and rumination intensity, emotion regulation strategy use, and successful emotion regulation strategy implementation will be examined as a function of the intervention.

    Time frame: Baseline and 4 weeks

  4. Improvements on a Self-Report Measure of Emotion Dysregulation

    Emotion Dysregulation will be assessed using the Difficulties in Emotion Regulation Scale (DERS). Changes on the total score and sub-facets of DERS will be examined as a function of the intervention.

    Time frame: Baseline and 4 weeks

  5. Improvements on a Self-Report Measure of Depression

    Participants will be administered Beck Depression Inventory before and after the intervention. Change on this measure will be examined to assess the impact of the interventions on symptoms of depression.

    Time frame: Baseline and 4 weeks

  6. Improvements on a Self-Report Measures of Anxiety

    Participants will be administered Penn State Worry Questionnaire before and after the intervention. Change on this measure will be examined to assess the impact of the interventions on symptoms of worry.

    Time frame: Baseline and 4 weeks

  7. Improvements on a Self-Report Measure of Perceived Stress

    Participants will be administered the Perceived Stress Scale before and after the intervention. Changes in these measures will be examined as a function of the intervention.

    Time frame: Baseline and 4 weeks

  8. Improvements on a Self-Report Measure of Quality of Life

    Participants will be administered the Satisfaction with Life Scale before and after the intervention. Change in scores of this measure will be examined to assess changes in quality of life as a function of the interventions.

    Time frame: Baseline and 4 weeks

07

Study locations

1 site
  • Department of Psychology, The Ohio State University
    Columbus, Ohio 43210, United States
08

References and documents

Publications

  • Duraney EJ, Fisher ME, Manglani HR, Andridge RR, Nicholas JA, Prakash RS. Impact of mindfulness training on emotion regulation in multiple sclerosis: Secondary analysis of a pilot randomized controlled trial. Rehabil Psychol. 2022 Nov;67(4):449-460. doi: 10.1037/rep0000456. Epub 2022 Jul 28. PubMed 35901401 ↗
  • Schirda B, Duraney E, Lee HK, Manglani HR, Andridge RR, Plate A, Nicholas JA, Prakash RS. Mindfulness training for emotion dysregulation in multiple sclerosis: A pilot randomized controlled trial. Rehabil Psychol. 2020 Aug;65(3):206-218. doi: 10.1037/rep0000324. Epub 2020 May 7. PubMed 32378922 ↗
  • Manglani HR, Samimy S, Schirda B, Nicholas JA, Prakash RS. Effects of 4-week mindfulness training versus adaptive cognitive training on processing speed and working memory in multiple sclerosis. Neuropsychology. 2020 Jul;34(5):591-604. doi: 10.1037/neu0000633. Epub 2020 Apr 30. PubMed 32352832 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02717429
Lead sponsor
Ohio State University
Responsible party
Ruchika Prakash (Assistant Professor, Ohio State University) — Principal investigator
First posted
Mar 23, 2016
Start date
Oct 2015
Primary completion
May 14, 2017
Completion
May 14, 2017
Last update
Apr 17, 2018

Study contacts

Ruchika S Prakash, PhD
principal investigator · Ohio State University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion